Emisphere matches loss from last year first quarter
-
- May
- 7
Emisphere Technologies Inc., the biopharmaceutical company with research and development operations in Eastview, lost $3.9 million during the first quarter, matching its loss from the first quarter of last year.
On a per-share basis, this year’s loss was 13 cents, compared with 26 cents last year.
The company’s operating loss narrowed to $6.5 million from $7.1 million.
Emisphere, which has its headquarters in Cedar Knolls, N.J. does not have a marketable product yet but is seeking to introduce an oral form of vitamin B-12 that delivers high dosages of the nutrient during the second half of this year.
This entry was posted
on Wednesday, May 7th, 2008 at 8:57 am by Allan Drury.
You can follow any responses to this entry through the RSS 2.0 feed.
Share and Enjoy: 
| 
Print
| 
Email
